Is the HSBC share price the FTSE 100’s best bargain?

The HSBC (LON: HSBC) share price is up 20% over 12 months. But I think it’s still great value, and I’d buy for long-term passive income.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I wish I’d bought HSBC Holdings (LSE: HSBA) when it dipped in the first days of the war in Ukraine. The whole financial sector suffered a sharp drop. But since a low on 7 March, the HSBC share price has risen 15%. And even with this latest financial shock, HSBC is up 20% over the past 12 months.

The valuation still looks modest to me. And the bank is paying very attractive dividend yields. So is HSBC the FTSE 100’s best bargain right now? There are risks, but I think it could well be up there. And I’m seriously thinking of buying.

Going on 2021 full-year results, HSBC is on a price-to-earnings (P/E) multiple of 11 with a dividend yield of 3.7%. That’s on the current HSBC share price, and I’d clearly have done better had I bought at the end of 2021. But I still think that’s a bargain buy valuation, providing we see further progress in 2022 and beyond. And I think we will, judging by current forecasts.

Profit growth

The bank itself reckons it will continue to make progress with costs savings in the current year, and the forecasts echo that. The consensus suggests adjusted pre-tax profit should dip slightly, by 4% in the current year, but then rise in the following two years. By 2024, we could be looking at a pre-tax profit figure that’s 20% ahead of 2021.

That might sound like modest progress. But considering the geopolitical unrest we’ve seen, including growing tensions between the US and China, I’d be very happy with it. It suggests a year-end P/E for 2024 of only around nine, based on today’s HSBC share price.

Strong liquidity

Since the banking crisis, attention has been focused mainly on liquidity measures. The result, I reckon, is that our banks are safer and more financially secure today than they’ve been for a good few decades. HSBC was able to boast a common equity tier 1 capital ratio of 15.8% in 2021. That’s way better than any of the targets set by the Bank of England in its stress tests on UK-listed banks.

What’s the risk? The Ukraine conflict has focused financial attention on Russia. And that has, perhaps, drawn our attention away from those long-term trade and political conflicts between China and the US. Those conflicts have shaken a number of Chinese stocks with listings on American stock markets. And anything that hampers global trade has to be bad news for a multinational bank like HSBC.

HSBC share price outlook

Still, even with the risks, I still feel bullish about the HSBC share price. Interest rates are rising across the world, with the Bank of England and the US Federal Reserve both lifting them. That’s bad news for borrowers, but good news for banks.

Those higher rates could help push up HSBC’s profits in the next few years. And with HSBC continuing to “target dividends within our 40% to 55% dividend payout ratio range“, that would feed through to more cash in shareholders’ pockets.

But yes, overall, I think HSBC is one of the FTSE 100’s most attractive shares at the moment. And I might add some to my portfolio.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »